CS logo
small CS logo
Lowcountry Lung and Critical Care

Charleston, South Carolina, United States
Doctor in North Charleston, South Carolina
9150 Medcom St B, North Charleston, SC 29406

About Lowcountry Lung and Critical Care


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Lowcountry Lung and Critical Care


During the past decade, Lowcountry Lung and Critical Care conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 11 clinical trials were completed, i.e. on average, 47.8% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 7 clinical trials were completed. i.e. 46.7% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Lowcountry Lung and Critical Care" #1 sponsor was "Boehringer Ingelheim" with 8 trials, followed by "Jazz Pharmaceuticals" with 4 trials sponsored, "FibroGen" with 2 trials sponsored, "Harmony Biosciences, LLC" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 15 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Lowcountry Lung and Critical Care" #1 collaborator was "Iqvia Pty Ltd" with 2 trials as a collaborator and "LGC Limited" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at Lowcountry Lung and Critical Care


According to Clinical.Site data, the most researched conditions in "Lowcountry Lung and Critical Care" are "Idiopathic Pulmonary Fibrosis" (8 trials), "Chronic Obstructive Pulmonary Disease" (5 trials), "Narcolepsy" (5 trials), "Obstructive Sleep Apnea" (3 trials) and "Pulmonary Disease, Chronic Obstructive" (3 trials). Many other conditions were trialed in "Lowcountry Lung and Critical Care" in a lesser frequency.

Clinical Trials Intervention Types at Lowcountry Lung and Critical Care


Most popular intervention types in "Lowcountry Lung and Critical Care" are "Drug" (28 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (12 trials), "JZP-110" (3 trials), "Nintedanib" (3 trials), "BI 1015550" (2 trials) and "PRM-151 (Zinpentraxin Alfa)" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Lowcountry Lung and Critical Care


The vast majority of trials in "Lowcountry Lung and Critical Care" are 30 trials for "All" genders.

Clinical Trials Status at Lowcountry Lung and Critical Care


Currently, there are NaN active trials in "Lowcountry Lung and Critical Care". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 20 completed trials in Lowcountry Lung and Critical Care, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Lowcountry Lung and Critical Care, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".